|
ハギワラ シヨウタロウ
Hagiwara Shiyoutarou
萩原 將太郎 所属 医学部 医学科（東京女子医科大学病院） 職種 非常勤講師 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: The Tokyo Women's Medical University model. |
| 掲載誌名 | 正式名：Respiratory investigation 略 称：Respir Investig ISSNコード：22125353/22125345 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 59(3),pp.356-359 |
| 著者・共著者 | Arimura Ken†, Tagaya Etsuko, Kikuchi Ken, Mitsuda Toshihiro, Yasuda Gaku, Azuma Haruna, Konda Naoko, Ikarashi Yuichi, Chiba Yukihide, Kusama Kaoru, Sakama Reiko, Hagiwara Shotaro, Shimizu Satoru, Shimamoto Ken, Nomura Minoru, Yaguchi Arino, Niinami Hiroshi, Kondo Mitsuko, Tanabe Kazunari, Kawana Masatoshi |
| 発行年月 | 2021/05 |
| 概要 | Hospital-acquired severe acute respiratory virus coronavirus 2 (SARS-CoV-2) infection is a healthcare challenge. We hypothesized that polymerase chain reaction testing of symptomatic triaged outpatients and all inpatients before hospitalization in Shinjuku, a coronavirus disease 2019 (COVID-19) epicenter in Tokyo, using the Tokyo Women's Medical University (TMWU) model would be feasible and efficient at preventing COVID-19. This retrospective study enrolled 2981 patients from March to May 2020. The prevalence of SARS-CoV-2 infection was 1.81% (95% credible interval [CI]: 0.95-3.47%) in triaged symptomatic outpatients, 0.04% (95% CI: 0.0002-0.2%) in scheduled asymptomatic inpatients, 3.78% (95% CI: 1.82-7.26%) in emergency inpatients, and 2.4% (95% CI: 1.49-3.82%) in symptomatic patients. There were no cases of hospital-acquired SARS-CoV-2 infection. This shows that the TWMU model could prevent hospital-acquired SARS-CoV-2 infection and is feasible and effective in reducing the impact of SARS-CoV-2 infection in the hospitals. |
| DOI | 10.1016/j.resinv.2020.12.009 |
| PMID | 33579647 |